Amylyx Pharmaceuticals, Inc. (AMLX)
28.91
-0.29
(-0.99%)
USD |
NASDAQ |
Nov 04, 14:08
Amylyx Pharmaceuticals Market Cap : 3.220B for Nov. 4, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 03, 2026 | 3.252B |
| November 02, 2026 | 3.123B |
| October 30, 2026 | 3.214B |
| October 29, 2026 | 3.194B |
| October 28, 2026 | 3.126B |
| October 27, 2026 | 3.152B |
| October 26, 2026 | 3.017B |
| October 23, 2026 | 3.029B |
| October 22, 2026 | 3.182B |
| October 21, 2026 | 3.233B |
| October 20, 2026 | 3.204B |
| October 19, 2026 | 3.044B |
| October 16, 2026 | 2.933B |
| October 15, 2026 | 3.079B |
| October 14, 2026 | 3.010B |
| October 13, 2026 | 2.990B |
| October 12, 2026 | 3.060B |
| October 09, 2026 | 3.134B |
| October 08, 2026 | 3.029B |
| October 07, 2026 | 3.055B |
| October 06, 2026 | 3.123B |
| October 05, 2026 | 3.094B |
| October 02, 2026 | 3.095B |
| October 01, 2026 | 3.127B |
| September 30, 2026 | 3.241B |
| Date | Value |
|---|---|
| September 29, 2026 | 3.261B |
| September 28, 2026 | 3.324B |
| September 25, 2026 | 3.284B |
| September 24, 2026 | 3.357B |
| September 23, 2026 | 3.408B |
| September 22, 2026 | 3.675B |
| September 21, 2026 | 3.607B |
| September 18, 2026 | 3.609B |
| September 17, 2026 | 3.780B |
| September 16, 2026 | 3.634B |
| September 15, 2026 | 3.692B |
| September 14, 2026 | 3.746B |
| September 11, 2026 | 3.521B |
| September 10, 2026 | 3.574B |
| September 09, 2026 | 3.608B |
| September 08, 2026 | 3.773B |
| September 04, 2026 | 3.798B |
| September 03, 2026 | 3.782B |
| September 02, 2026 | 3.841B |
| September 01, 2026 | 3.765B |
| August 31, 2026 | 3.759B |
| August 28, 2026 | 3.869B |
| August 27, 2026 | 4.141B |
| August 26, 2026 | 4.130B |
| August 25, 2026 | 4.172B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 174.79B |
| Eli Lilly & Co. | 1.341T |
| Merck & Co., Inc. | 366.89B |
| Bristol Myers Squibb Co. | 129.30B |
| ANI Pharmaceuticals, Inc. | 1.658B |
Market Cap Related Metrics
| Price to Book Value | 13.46 |
| Price | 28.91 |
| Earnings Yield | -4.96% |